With fiscal 2013 budgets coming out, many drugmakers are making some drastic cuts, especially on marketing departments. “I expected my budget to get cut but I didn’t expect this much of a cut,” one marketing director told blogger Rich Meyer. The challenge for many drugmakers is the number of drugs coming off patent, leading to less revenue. Additionally, costs to develop new drugs are increasing. “We all have to do more with less and DTC marketing is now learning that less is a lot less,” Meyer adds.